Orthotopic Replacement of Aortic Heart Valves with Tissue-Engineered Grafts

Abstract

Tissue-engineered AV based on decellularized valve allografts satisfy short-term requirements of the systemic circulation in sheep. Although results of long-term experiments are pending, the lack of degenerative traits thus far, makes these grafts a promising alternative for future aortic heart valve surgery.